To verify whether Nuplazid affects the proliferation of esophageal cancer cells through PAK4, shPAK4-KYSE150, shPAK4-KYSE450 cells and their control sh-mock cells were treated with 2.5 μM Nuplazid. The gene discussed is PAK4; the disease is esophageal cancer.